Table 1.
Clinical features of pyomyositis in patients with systemic lupus erythematous.
| Reference | Age/sex | Country | Therapy | Muscles | Organism | Antibiotics | Outcome |
|---|---|---|---|---|---|---|---|
| Dede et al. [3] | 23/F | Turkey | HCQ | Gastrocnemius | S. aureus | yes | Recovery |
| Claudepierre et al. [4] | 32/F | France | Pred + Cyclo | Quadriceps | S. aureus | 4 weeks | Recovery |
| Ravindran and Duke [5] | 34/F | UK | Pred + HCQ | Pronator teres | S. aureus | 4 weeks | Recovery |
| Souza et al. [6] | 25/F | Brazil | — | Iliacus muscle | S. aureus | 6 weeks | Recovery |
| Baaj et al. [7] | 47/F | Morocco | Pred | Quadriceps | E. coli | 3 weeks | Recovery |
| Present case | 52/F | Tunisia | HCQ + Pred + MMF | Iliacus, gluteal | S. aureus | 6 weeks | Recovery |
F: female; HCQ: hydroxychloroquine; Pred: prednisolone; Cyclo: cyclophosphamide; MMF: mofetil mycophenolate; S: staphylococcus; E: Escherichia.